News

Sedative medetomidine, or 'dex,' complicates battle against fentanyl

Safety 72/100Rated 72/100Source typeEstablished referenceIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
July 30, 2026↗ source

Medetomidine and its active isomer dexmedetomidine ('dex') are rapidly replacing xylazine ('tranq') as adulterants in the illicit fentanyl supply. Reports from cities like Philadelphia indicate a massive surge in prevalence, rising from 29% to 87% of fentanyl samples within months. This shift complicates overdose reversal and causes severe health complications, including heart and brain damage and agonizing withdrawal symptoms.

Related peptides

Versa
We summarize, we don't invent — every detail here traces to a real, linked source, and the badge reflects how trustworthy that source is. Read the original and decide for yourself.

Free: The Peptide Stack Cheat-Sheet

The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.

No spam. Unsubscribe anytime.